Addressing increasingly resistant drugs by infectious agents
Drug Target Review
SEPTEMBER 4, 2023
7,9 Dihydrofolate reductase-thymidylate synthase (DHFR) have been successfully exploited for the therapy of bacterial infections and other parasitic diseases such as malaria. 2017): Antitrypanosomatid drug discovery: an ongoing challenge and a continuing need, Nature Review Microbiology, 15(4): 217–231. doi.org/10.5772/intechopen.770301
111 
Let's personalize your content